The drug blocks the activity of a protein known as mammalian target of rapamycin (mTOR), which promotes proliferation through the activation of proteins such as S6 kinase. Although the mTOR ...
The mTOR complex 1 (mechanistic Target of Rapamycin complex 1, in short ‘mTORC1’) is the central component of a protein network that senses whether a cell has access to sufficient nutrients. Therefore ...
In an eagerly awaited study, Memorial Sloan Kettering researchers report on the molecular structure of mTOR, a protein commonly mutated in cancer. Structural Biology Program Chair Nikola P. Pavletich ...
Am J Health Syst Pharm. 2010;67(24):2095-2106. The second mTOR complex, mTORC2, contains mTOR, mLST8, and several unique proteins, including rictor (rapamycin-insensitive companion of mTOR).